Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB Defining Individual Outcomes and Public Health Impact

NCT03251196 is registered in ClinicalTrials.gov with The Aurum Institute NPC as lead sponsor.

NCT NCT03251196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03251196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB Defining Individual Outcomes and Public Health Impact
Lead sponsor
The Aurum Institute NPC
Phase
Observational
Overall status
Unknown status
Start date
September 22, 2017
Completion date
June 30, 2022
Enrollment
1,500 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory tract infections, tuberculosis, pulmonary